Thus, both gain-of-function and loss-of-function mutations in EZH2 can result in chromatin remodeling, which in turn promotes tumor development by either repressing tumor suppressor genes or expressing oncogenes [257]. The gene discussed is EZH2; the disease is neoplasm.